Author:
Hellström Karl Erik,Hellström Ingegerd
Reference21 articles.
1. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts;Baselga;Cancer Res.,1998
2. CA125;Bast;Int. J. Biol. Mark.,1998
3. Tumor antigens recognized by T cells;Boon;Immunol. Today,1997
4. T-cell recognition of melanoma-associated antigens;Castelli;J. Cell Physiol.,2000
5. Tumors express both unique TSTA and crossprotective 44kDa oncofetal antigen;Coggin;Immunol. Today,1998